chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore; little tired; itches; He started to breakout on his back; This spontaneous case was reported by a patient and describes the occurrence of PAIN (sore), PRURITUS (itches), RASH (He started to breakout on his back) and FATIGUE (little tired) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 028L20A) for COVID-19 prophylaxis.     Patient did not describe Medical history or condition.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced PRURITUS (itches) and RASH (He started to breakout on his back). On an unknown date, the patient experienced PAIN (sore) and FATIGUE (little tired). At the time of the report, PAIN (sore), PRURITUS (itches), RASH (He started to breakout on his back) and FATIGUE (little tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant medication details not reported by the reporter. It was reported that patient had no problem until last September beside of the general side effects of being a little tired and sore. Treatment details was not reported by the reporter.
I received my first Moderna COVID-19 booster on 11/8/2021. In mid-to late January 2022, I developed a headache, severe malaise, body aches, shortness of breath, and cough. There was an 18-hour period in which I couldn't speak, because I wasn't able to get enough breath to speak. Despite this, though, I did not go to the ER. The illness lasted 7-10 days. Afterwards, I had a diminishing cough, severe malaise, chills, and body aches. I didn't see a doctor, so I just treated my symptoms with Motrin and TYLENOL, which were helpful with the aches and pains. At night, I took NYQUIL, which partially resolved the coughing issue, so I was able to get some sleep. After my illness, I would say that the residual symptoms lasted for about 10 days. This was my second breakthrough case. I received my second dose of Moderna COVID-19 vaccine (030L20A) on 1/19/2021 and had my first breakthrough in April 2021.
Patient was  given an expired dose of the vaccine.  The vaccine expired on 9/13/22 and was given on 9/23/22 Patient  condition was the same after the injection as it was before injection Physician was notified and she did not want vaccine repeated
I21.4 ACUTE NON ST ELEVATION MI 4/17/2022 CHRONIC HYPOXEMIC RESPIRATORY FAILURE J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/13/2022 CHRONIC HYPOXEMIC RESPIRATORY FAILURE I21.4 ACUTE NON ST ELEVATION MI 4/17/2022 PNEUMONIA J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/13/2022 PNEUMONIA
Stiffness of right leg.  Patient was unable to bend it at the knee.  Mom was advised to work with the leg, to gradually flex it.
After receiving the vaccine on Friday, the patient broke out in hives on Saturday evening on her arms and chest. She reported some itching, but no trouble breathing was noted. She used diphenhydramine and a few unknown anti-itch lotions with only marginal effect.
headaches, muscle pain, problems breathing, cough, nausea, chest pain. vision problems.
when RN went to vaccinate the individual  the needle went into his arm and clear fluid ran down his arm and onto the vaccinators gloves.
I waited for fifteen minutes and I was a little dizzy, I had had a strange taste in my mouth within a few minutes of the shot. When I got the next morning and I was still dizzy and my blood pressure was very high. I went to the ER and I was advised to take Ibuprofen 800 mg. I took the medication as advised the next day I noticed that the area around where I got the shot was very hard and sore. It is swollen and red with a ring around the site of the shot. On the third day my arm was itchy and I tried some Benadryl. My arm was warmer and warmer and I went to the doctor. It has been five days and my arm is still very warm so the doctor advised to take some Benadryl and he gave me Prednisone.
L upper arm red pink diffuse area 5cm x5cm with upper central induration soft 2cm not flluctuatnt, deprsible , not tender, no secretion
was injected on 1MAR93 @ approx 345PM & notice that site was painful in later PM but early AM site was swollen & hot & painful;
Intense itching; began on left breast and spread to arms and back area, skin began to welt over entire body.
Hives presented about 11 hrs after injection. Neck, back, behind ears, scalp, a few on face. Used hydrocortisone cream for relief but has resurged 10/15/18 am.
Chills starting 5pm day of vaccine. Progressed to a fever over the course of the evening. High fever throughout the night & delirium.   Next day had general fatigue, muscle aches, low grade fever. Slight fever during night 2  Fully recovered on day 3.
Colitis ulcerative aggravated; Crohn's disease aggravated; Lactose intolerance; FELT TERRIBLE/SO BAD; ACHES AND PAINS; LIKE A BAD FLU; This case was reported by a consumer via other manufacturer and described the occurrence of colitis ulcerative aggravated in a 68-year-old male patient who received Herpes zoster (Hz/su + AS01B) for prophylaxis.   Co-suspect products included COVID-19 VACCINE for prophylaxis.   Previously administered products included Humira (received Humira on unknown date in 2005). Concurrent medical conditions included lactose intolerance, crohn's disease and ulcerative colitis.   On an unknown date, the patient received Hz/su + AS01B and COVID-19 VACCINE (intramuscular). On an unknown date, unknown after receiving Hz/su + AS01B, the patient experienced colitis ulcerative aggravated (serious criteria GSK medically significant), crohn's disease aggravated (serious criteria GSK medically significant), lactose intolerance, feels awful, pain and influenza. On an unknown date, the outcome of the colitis ulcerative aggravated, crohn's disease aggravated, lactose intolerance, pain and influenza were unknown and the outcome of the feels awful was recovered/resolved.   It was unknown if the reporter considered the colitis ulcerative aggravated, crohn's disease aggravated, lactose intolerance, feels awful, pain and influenza to be related to Hz/su + AS01B.  Additional details were provided as follows: The age at vaccination was not reported. The patient had medical history of lactose intolerance and crohn's disease. The patient received Shingrix, Covid 19 vaccine and experienced lactose intolerance, crohn's disease aggravated, ulcerative colitis aggravated, felt terrible and bad flu. It was unknown if the reporter considered the colitis ulcerative aggravated, crohn's disease aggravated, lactose intolerance, feels awful, pain and influenza-like symptoms to be related to Covid-19 vaccine
Soreness at deltoid injection site spread to an extensor muscle of left arm just below the elbow 1 day after injection. Extensor has remained sore to this date despite initial resting and then minor hand grip exercise.  The second injection was in the right deltoid and did not produce a similar reaction (other than injection site tenderness and rash which have both subsided as of 4/11/21).  Injection #2 was given on 4/3/21 at 4:15pm, moderna lot: 026A21A.  The residual soreness of the left forearm was reported at the time of the second injection and deemed not significant enough to delay the 2nd dose, and maybe not related to the initial vaccine.  Tenderness of the left forearm has not increased with the 2nd dose. I have deemed this very minor soreness that tends to lessen with stretching and exercise, but just hasn't gone away yet. Please let me know if I should be more concerned than giving it mention at my next annual physical in November 2021 if stiffness/soreness is still present.
This spontaneous report as received from a licensed practical nurse refers to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions and medical history were not reported. On an unspecified dates since June 2015, the patients were vaccinated with doses of VARIVAX (Merck) (lot#K007781, expiration date: 28-MAY-2016 and lot# reported as K006134, expiration date: 29-APR-2016; dose and route were not provided), that have been exposed to temperatures outside of the recommended range. No adverse effects have been reported. Additional information has been requested.
Child vomited. Fever 101 to 103 degrees lasting 24 hours.  Children's Tylenol 1.5 ML every 4 hours to control fever.
Information has been received from a registered nurse regarding a patient of unknown age and gender. On 03-MAR-2012 at 11:30, ZOSTAVAX (Lot # 672477/1604AA) was exposed to -12 degrees C for an estimated total time out of range of 4 hours. On 28-MAR-2012, the patient was vaccinated with an out of range dose of ZOSTAVAX, lot # 672477/1604AA, expiration date: 13-JAN-2013 (dose and route not reported). No adverse experience was reported. This is one of 182 reports received from the same source. Additional information has been requested.
S/P 24 hours vaccine: Fatigue, body aches, nausea, headache and brain fog - No treatment Headaches lasted for 1 week and continues to have increase in Migraine headache episodes. Treated with Aimovig ( not effective ), and Excedrine PRN  S/P 36 hours: Burning, pruritic, erythematous flat rash ( with small amount of raised areas ) Trunk, abdomen, BLU, BUE, neck, and face. S/P 1-2 weeks skin peeling of hands and forearms Pruritis continued for 2 weeks  Rash was treated at home with ice packs and Benadryl 25-50 mg Q4-6 hours with minimal relief.  Did not seek medical treatment
Delayed Chronic Spontaneous Uticaria. All over body. Daily occurrences starting 10 day after vaccine and lasting until today 3 weeks later
severe flu symptoms experienced two days after vaccine for one week. Two days of apparent relief, then severe symptoms again. Headache, very tired, inability to focus for very long. Nausea.
No additonal AE's; expired dose of VAQTA that was administered to a patient; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided.  On 05-MAY-2022, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) pre-filled syringe, lot #U003464, expiration date: 02-MAY-2022 (strength, site and route of administration were not provided) for prophylaxis (Expired product administered). No adverse events were reported (No adverse event).
Post vaccination, HCW reports she sustained Right arm swelling, pain,  warmness to touch.  Red spots were noted at injection site and was warm to touch.  HCW reported staggering Motrin 800mg and Tylenol 1000mg around the clock for a period of 3 days.  Also used cold compress to to right arm.   On 01/12/2021, 5 days post vaccination, HCW reports some relief in pain , decrease in arm swelling  and improvement in redness at the injection site.  The HCW sought evaluation at the facility's Occupational Health Center and  was instructed to continue Motrin and cold compress and  report back if symptoms worsens.
Patient completed the series unknowingly in 2020 and did not require a 3rd dose. This was discovered after administration. No treatment was necessary.
04/16/21 - General fatigue and lack of focus for several hours, beginning approx 4 hrs after injection. Unknown duration (was gone after sleeping) 04/16/21 through 04/17/21 - Injection site soreness for approx 24 hours. 04/17/21 - Body chills and feeling of low-grade fever (did not take temperature) for approx 10 hours, ending around 2am on 04/18/21.
I have ?covid arm? near my injection site.  It appeared a week after my vaccine. It is red and swollen.  It itches at times and it painful at times.
This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 13-OCT-2012 10:46, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot # were involved and the lot # were reported as; 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. IT was unspecified which lot # the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. this is one of several reports received from the same source. Additional information has been requested.
According to patient about 1 hr after vaccination her arm (left) started swelling and was warm to touch from shoulder to elbow and by 8/25/13 (2 days after) the swelling had gone all the way to her middle arm. Patient treated swelling with ice and around 3 AM (8/25) swelling started going down.
really sore and she could not sleep on it; she had COVID-19/tested positive for COVID; left arm was very sore; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 04Mar2021 at 11:30 (Lot Number: EN6206) as 1st dose, single for covid-19 immunisation, administered at the hospital. Medical history included high blood pressure, diagnosed many years ago; diabetes, diagnosed 4 1/2 years around age 65 and a half, she is not on Insulin shots, just on Metformin; obese and overweight, she has been heavy all of her life since age 16-17; and allergies to Novocain at the dentist office and allergies to Sulfa. When she had Shingles shot first one, she reacted to it. She took Tylenol and it took care of it. She never went to the ER or doctor. There were no concomitant medications. The patient stated that she had COVID-19. Her quarantine period was 15Mar2021 through 25Mar2021. She received only first dose of Pfizer-BioNTech COVID-19 Vaccine on 04Mar2021 but could not get the second dose since she was still in the quarantine period, getting over the COVID-19 infection. She stated: "I'm pretty much over my symptoms, still have a little bit of cough but nothing dangerous or anything" "They already re-scheduled me for second dose appointment 01Apr2021 and wanted to make sure it is safe, won't make me sick again". The patient was supposed to have second dose on 25Mar2021. She caught COVID in between. She caught COVID on 15Mar2021. She later stated she did not get tested until 20Mar2021 and got results on 22Mar2021. They wanted her to take last shot this Thursday. She wants to know if she will be sick again and is worried.  She would like some guidance about getting second dose since she tested positive for COVID after receiving the first dose. She said it took two days to get results because they do not have a fast test where she is. She had a terrible dry cough for 2 days that started on 15Mar2021, or 16Mar2021, noticed a terrible cough at 12:00. By 16Mar2021, she was coughing, but the drainage did not start until 17Mar2021. She still had the cough but a lot of drainage on 17Mar2021.  She still has a slight cough, but it is not bad and does not keep her up. Her left arm was very sore on 04Mar2021 at 15:00. It lasted for 2 days. It was really sore and she could not sleep on it. The patient tested positive for COVID on 20Mar2021 at 08:22. The patient's COVID symptoms started on 15Mar2021. No emergency room or physician's office visit required. Outcome of the event left arm was very sore was recovered on 06Mar2021, outcome of event really sore and she could not sleep on it was unknown, and outcome of other event was recovering.
Patient was given Moderna Vaccine under the age of 18. Patient had no adverse reaction other than a sore arm. Did not receive second dose.
presented to ED with AMS. acute stroke( not a TPA candidate) and Hepatic encephalopathy, had missed lactulose for last 2 days . PMHX  CAD and MI
Patient had Pfizer dose on 03/17/2021 and missed second appointment for second dose and the patient thought he needed to start over. We were doing a second dose Moderna clinic at his workplace and he came in for his first dose of Moderna. We discovered this information when we tried to bill for the Moderna vaccine. We notified the patient and he is not having any side effects to day. We discussed that he will most likely not need any more doses and that we would be in contact when we get more information.
This is a spontaneous report from a contactable nurse (patient). A 65-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection), via an unspecified route of administration, on Feb 10, 2021, single dose, for COVID-19 immunisation. The patient's medical history included tested positive for COVID-19 on Nov 28, 2020, to an unknown date. The patient's concomitant medications not reported. On an unspecified date, patient experienced headache and fatigue. Patient inquired if she can take Tylenol for the headaches and asked how long do the headaches last. Her hospital protocol recommends taking Zinc 50 mg, Cosequin 500 mg twice daily and vitamin C 500 mg twice daily. She asked if there are any recommendations on these and inquired about hydroxychloroquine and ivermectin. The outcome of the events: unknown. Batch/lot number requested. Follow-up attempts completed. No further information expected.
Immediately after: blacked out/passed out/ got extremely hot, extremely dizzy, confused, disoriented The same night and next day: very weak, dizzy, arm pain, felt 'off', fevers.
Vaccine given 4/23/09 - Pt began having myoclonic jerk seizures about 5 hours later. Pt told to go to ER ASAP. LP, EEG, MRI, CT had all WNL. Currently seeing Peds neurologist. Will hold off in DTAP until fully stable.
Rash (Red) on legs & left side of face around mouth. Joint aches (legs & ankles) and pain in center of my back.
Flu-like symptoms including chills, fatigue, muscle soreness, nausea. No fever. Symptoms lasted roughly 24hrs.
Well I felt like I had a cold, or allergies, post nasal drip, cough, then I had a low grade fever of 99.7 that made me concerned so I went to get tested for Covid and got the results that I was positive. But before I got those results I called my PCD on 7/27/2021 and they told me to go in and get examined as well, even though I did have a test in progress. They put me on an antibiotic (clarithromycin), then after getting my results I told them I got them and I was positive. They told me ok, to drink plenty of fluids and rest. I also called my Rheumatologist and they wanted me to stop a medication I was taking for two weeks. I have been feeling a little better, right now I just feel like I have a bad cold and today is 7/29/2021, again this all started 7/25/2021. On July 12, I did feel like I had a cold and I saw my DR then as well, that was just the post nasal drip and the cough and she just told me to take Z-Pak which helped immediately and then I was fine until it started again on the 25th of July, the cough, post nasal drip and fever.
Immediately got dizzy, had pins and needles in the arm and hand on the injection side also has swelling of the face on that side and itching at injection site. Layer that evening and the next day I had heart erratic heart rate
weak; body pain all over; chills; fever of 37.5 degree Celsius that comes and goes; tired/fatigued; got the 2nd dose about 45 days after the 1st dose; This spontaneous case was reported by a physician and describes the occurrence of ASTHENIA (weak), PAIN (body pain all over), CHILLS (chills), PYREXIA (fever of 37.5 degree Celsius that comes and goes) and FATIGUE (tired/fatigued) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weak), PAIN (body pain all over), CHILLS (chills), PYREXIA (fever of 37.5 degree Celsius that comes and goes), FATIGUE (tired/fatigued) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got the 2nd dose about 45 days after the 1st dose). At the time of the report, ASTHENIA (weak), PAIN (body pain all over), CHILLS (chills) and FATIGUE (tired/fatigued) outcome was unknown, PYREXIA (fever of 37.5 degree Celsius that comes and goes) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (got the 2nd dose about 45 days after the 1st dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 37.5 degree celsius (High) fever : 37.5 degree celsius.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported.  No treatment information was provided.   This case was linked to MOD-2021-337036.
This case was reported by a consumer via other manufacturer and described the occurrence of vasculitis aggravated in a adult patient who received Shingrix for prophylaxis. Concurrent medical conditions included vasculitis and microscopic polyangiitis. On 6th August 2018, the patient received the 1st dose of Shingrix. In August 2018, less than a month after receiving Shingrix, the patient experienced vasculitis aggravated, microscopic polyangiitis and condition aggravated. On an unknown date, the outcome of the vasculitis aggravated, microscopic polyangiitis and condition aggravated were unknown. It was unknown if the reporter considered the vasculitis aggravated, microscopic polyangiitis and condition aggravated to be related to Shingrix. Additional details were provided as follows: The patient's past medical history was not reported. The patient's concomitant condition was not reported. The age at vaccination was not reported. The patient experienced flare Microscopic polyangiitis (MPA) vasculitis. No further information was reported.
Pt had reaction to PROQUAD on left thigh of 1.5 x 1.5 cm with red induration. Pt waited for 15 mins no reaction. VIS given.
Mother called clinic 5/3/07 to son's report symptoms of fever of 102.3, chills, shaking of right arm (injection site), weakness, pain 2-3" below injection site which began this AM.  Injection was given 5/2/07 at 3:45 PM.  Mother denies other symptoms of unrelated infection, such as upper respiratory infection.
Information has been received from a physician's assistant concerning a 16 month old patient who in December 2002, was vaccinated with a dose of varicella virus vaccine live. On 4/14/03 the patient presented with a dermatome rash that appeared to be shingles, described as a papular rash, no intake vesicles, some crusted lesions in three groups on the right side of the back and spread to the right side of the chest. It was noted that the rash did not cross the mid line and the child was afebrile. Unspecified medical attention was sought. Additional information has been requested.
This spontaneous report as received from a physician refers to a 4 years old female patient. The patient started to get local swelling at the injection site after receiving (Merck) PROQUAD (lot # H015643; exp. Date was unknown; dose 2; 0.5 ml) on 11-JAN-2013 which may have been exacerbated by the patient scratching the site. The patient sought medical attention. The patient's reaction was now healing. Additional information is not expected.
Moderna COVID-19 Vaccine EUA Adverse events noted: Approximately 2 pm-altered sensation in maxillary lip and nose Approximately 4 pm-tingling on scalp just above nape of neck 6:18 pm-tingling in right hand  Each of the above events lasted about one minute  From approximately 6 pm to present-significant amounts of sneezing and a runny nose.